Janssen Pharmaceutica Completes Divestiture

BELGIUM - Janssen Pharmaceutica NV has completed the divestiture of its animal health business to Elanco.
calendar icon 8 July 2011
clock icon 2 minute read

Janssen Pharmaceutica NV, part of the Janssen Pharmaceutical Companies, has completed the divestiture of its Animal Health business to Elanco, a division of Eli Lilly and Company. Financial terms of the transaction are not being disclosed.

Under the terms of the transaction, Elanco acquires products, contracts and related intellectual property and marketing authorisations. The terms of the offer also include that the employees, active in 11 different countries, transfer to Elanco to support a significantly expanded portfolio of products.

© 2000 - 2022 - Global Ag Media. All Rights Reserved | No part of this site may be reproduced without permission.